Penn I, Starzl T E
Transplantation. 1972 Oct;14(4):407-17. doi: 10.1097/00007890-197210000-00001.
De novo malignant tumors have been observed throughout the world in 75 chronic survivors of organ transplantation, including 16 of our own patients. The incidence of tumors was approximately 80 times greater than in the average population in a comparable age range. Chronic uremia may have predisposed to the development of some of the tumors, but this has not yet been proved. It seems clear that the predominant etiology was chronic immunosuppression post-transplantation. Forty-four of the patients had epithelial tumors and in 31 the lesions were of mesenchymal origin. On the average the malignancies appeared 29 months after transplantation. Lymphomas showed an unusual predilection for involvement of the central nervous system. Carcinomas of the skin, lip, and uterine cervix were successfully treated by conventional techniques. On the other hand, carcinomas of the thoracic or abdominal organs and mesenchymal tumors led or contributed to early death in most cases. For this reason drastic reduction or even discontinuance of immunosuppression should be considered in the management of these latter tumors.
在全球范围内,已在75名器官移植慢性存活者中观察到新发恶性肿瘤,其中包括我们自己的16名患者。肿瘤发病率比年龄相仿的普通人群高出约80倍。慢性尿毒症可能是某些肿瘤发生的诱因,但尚未得到证实。显然,主要病因是移植后慢性免疫抑制。44例患者患有上皮性肿瘤,31例病变起源于间叶组织。恶性肿瘤平均在移植后29个月出现。淋巴瘤对中枢神经系统有异常的累及倾向。皮肤、唇和子宫颈癌通过传统技术成功治疗。另一方面,胸腹部器官癌和间叶组织肿瘤在大多数情况下导致或促成早期死亡。因此,在治疗后一类肿瘤时应考虑大幅减少甚至停用免疫抑制。